Prescription drug · ANDA
Loxapine NDC 70518-1792
Loxapine succinate 50 mg/1 · Capsule · Oral · REMEDYREPACK INC.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70518-1792-0 | 7051817920070518179200 | 1 CAPSULE in 1 POUCH (70518-1792-0)Marketed from Jan 11, 2019 | |
| 70518-1792-1 | 7051817920170518179201 | 100 CAPSULE in 1 BOX (70518-1792-1)Marketed from Feb 8, 2019 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Loxapine
- Generic name (nonproprietary)
- loxapine
- Active ingredients
- Loxapine succinate — 50 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- REMEDYREPACK INC.NDC labeler code 70518
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 090695
- Marketing start
- Listing expires
- Identifiers
- Product ID 70518-1792_56940755-b3ff-3300-e063-6294a90a7f93SPL ID 56940755-b3ff-3300-e063-6294a90a7f93SPL set ID 2d45dd3c-71c3-4cc1-92ac-6dcecb195dd2RxCUI 314075UNII X59SG0MRYU
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470518179200followed by a unit qualifier and the quantityPackage 70518-1792-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Loxapine Capsules, USP are indicated for the treatment of schizophrenia. The efficacy of loxapine in schizophrenia was established in clinical studies which enrolled newly hospitalized and chronically hospitalized acutely ill schizophrenic patients as subjects.
Excerpt only. Read the full label for complete information.
About NDC 70518-1792
- What is NDC 70518-1792?
- 70518-1792 is the product NDC for Loxapine, Loxapine succinate 50 mg/1 capsule, listed with the FDA by REMEDYREPACK INC.. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Loxapine.
- What is the active ingredient?
- Loxapine succinate.
- Who is the labeler?
- REMEDYREPACK INC., NDC labeler code 70518. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Loxapine?
- 21 other product NDCs are listed under this name. See all Loxapine NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Loxapine products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Loxapine | Loxapine succinate 50 mg/1 | CapsuleOral | REMEDYREPACK INC. | 70518-4311 | 70518-4311-00 |
| Loxapine | Loxapine succinate 25 mg/1 | CapsuleOral | Coupler LLC | 67046-1478 | 67046-1478-03 |
| Loxapine | Loxapine succinate 5 mg/1 | CapsuleOral | Coupler LLC | 67046-1479 | 67046-1479-03 |
| Loxapine | Loxapine succinate 10 mg/1 | CapsuleOral | Coupler LLC | 67046-1485 | 67046-1485-03 |
| Loxapine | Loxapine succinate 5 mg/1 | CapsuleOral | Elite Laboratories, Inc. | 64850-890 | 64850-0890-01 |
| Loxapine | Loxapine succinate 10 mg/1 | CapsuleOral | Elite Laboratories, Inc. | 64850-891 | 64850-0891-01 |
| Loxapine | Loxapine succinate 25 mg/1 | CapsuleOral | Elite Laboratories, Inc. | 64850-892 | 64850-0892-01 |
| Loxapine | Loxapine succinate 50 mg/1 | CapsuleOral | Elite Laboratories, Inc. | 64850-893 | 64850-0893-01 |
| Loxapine | Loxapine succinate 25 mg/1 | CapsuleOral | REMEDYREPACK INC. | 70518-1896 | 70518-1896-00 |
| Loxapine | Loxapine succinate 10 mg/1 | CapsuleOral | REMEDYREPACK INC. | 70518-1681 | 70518-1681-00 |
Other NDCs under ANDA 090695
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Loxapine | Loxapine succinate 5 mg/1 | CapsuleOral | Lannett Company, Inc. | 0527-1394 |
| Loxapine | Loxapine succinate 10 mg/1 | CapsuleOral | Lannett Company, Inc. | 0527-1395 |
| Loxapine | Loxapine succinate 25 mg/1 | CapsuleOral | Lannett Company, Inc. | 0527-1396 |
| Loxapine | Loxapine succinate 50 mg/1 | CapsuleOral | Lannett Company, Inc. | 0527-1397 |
| Loxapine | Loxapine succinate 5 mg/1 | CapsuleOral | Chartwell RX, LLC | 62135-492 |
| Loxapine | Loxapine succinate 10 mg/1 | CapsuleOral | Chartwell RX, LLC | 62135-493 |
| Loxapine | Loxapine succinate 25 mg/1 | CapsuleOral | Coupler LLC | 67046-1478 |
| Loxapine | Loxapine succinate 5 mg/1 | CapsuleOral | Coupler LLC | 67046-1479 |
| Loxapine | Loxapine succinate 10 mg/1 | CapsuleOral | Coupler LLC | 67046-1485 |
| Loxapine | Loxapine succinate 10 mg/1 | CapsuleOral | REMEDYREPACK INC. | 70518-1681 |
| Loxapine | Loxapine succinate 25 mg/1 | CapsuleOral | REMEDYREPACK INC. | 70518-1896 |
| Loxapine | Loxapine succinate 5 mg/1 | CapsuleOral | Proficient Rx LP | 82804-051 |